Association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes

16Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

OBJECTIVE - To clarify the association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes (T2D). RESEARCH DESIGN AND METHODS - This was an observational cohort study of 668 patients with T2D. Patients were classified into three groups by sex-specific tertile of leptin levels. Outcome measurements were the rate of change in estimated glomerular filtration rate (eGFR) and progression to a more advanced stage of albuminuria. RESULTS - Patients with low or high leptin levels had a steeper eGFR decline (-2.07 and -2.14 mL/min/1.73 m 2/year) than those with midrange leptin levels (-0.82 mL/min/1.73 m 2/year; P < 0.01), whereas patients with low leptin levels had an elevated risk of progression of albuminuria as compared with those with high leptin levels (hazard ratio 3.125 [95% CI 1.302-7.499]). CONCLUSIONS - Both low and high serum leptin levels were risk factors for kidney function decline. Meanwhile, lower serum leptin levels were associated with progression of albuminuria. © 2011 by the American Diabetes Association.

Cite

CITATION STYLE

APA

Hanai, K. O., Babazono, T., Mugishima, M., Yoshida, N., Nyumura, I., Toya, K., … Uchigata, Y. (2011). Association of serum leptin levels with progression of diabetic kidney disease in patients with type 2 diabetes. Diabetes Care, 34(12), 2557–2559. https://doi.org/10.2337/dc11-1039

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free